nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—Prostaglandins—Travoprost—glaucoma	0.142	0.5	CiPCiCtD
Latanoprost—Prostaglandins—Bimatoprost—glaucoma	0.142	0.5	CiPCiCtD
Latanoprost—PTGFR—glaucoma	0.14	1	CbGaD
Latanoprost—Travoprost—glaucoma	0.127	0.547	CrCtD
Latanoprost—Bimatoprost—glaucoma	0.105	0.453	CrCtD
Latanoprost—PTGFR—Travoprost—glaucoma	0.0903	0.619	CbGbCtD
Latanoprost—PTGFR—Bimatoprost—glaucoma	0.0519	0.355	CbGbCtD
Latanoprost—Iloprost—Bimatoprost—glaucoma	0.0322	0.223	CrCrCtD
Latanoprost—Tafluprost—Travoprost—glaucoma	0.0223	0.154	CrCrCtD
Latanoprost—Travoprost—Bimatoprost—glaucoma	0.0214	0.148	CrCrCtD
Latanoprost—Tafluprost—Bimatoprost—glaucoma	0.0185	0.128	CrCrCtD
Latanoprost—Dinoprost Tromethamine—Travoprost—glaucoma	0.0177	0.123	CrCrCtD
Latanoprost—Bimatoprost—Travoprost—glaucoma	0.0177	0.123	CrCrCtD
Latanoprost—Dinoprost Tromethamine—Bimatoprost—glaucoma	0.0147	0.102	CrCrCtD
Latanoprost—PTGFR—ciliary body—glaucoma	0.00866	0.948	CbGeAlD
Latanoprost—SLC22A1—Clonidine—glaucoma	0.00376	0.0258	CbGbCtD
Latanoprost—Travoprost—PTGFR—glaucoma	0.000523	0.395	CrCbGaD
Latanoprost—PTGFR—eye—glaucoma	0.000471	0.0516	CbGeAlD
Latanoprost—Tafluprost—PTGFR—glaucoma	0.000368	0.278	CrCbGaD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00036	0.186	CbGpPWpGaD
Latanoprost—Bimatoprost—PTGFR—glaucoma	0.000249	0.188	CrCbGaD
Latanoprost—Dinoprost Tromethamine—PTGFR—glaucoma	0.000151	0.114	CrCbGaD
Latanoprost—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.000113	0.0585	CbGpPWpGaD
Latanoprost—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	8.3e-05	0.0428	CbGpPWpGaD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	8.18e-05	0.0422	CbGpPWpGaD
Latanoprost—SLC22A1—Amine compound SLC transporters—SLC6A13—glaucoma	7.87e-05	0.0406	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—OPN4—glaucoma	6.32e-05	0.0326	CbGpPWpGaD
Latanoprost—SLC22A1—Neurotransmitter Release Cycle—SLC6A13—glaucoma	6.01e-05	0.031	CbGpPWpGaD
Latanoprost—SLC22A1—Amine compound SLC transporters—SLC6A1—glaucoma	5.76e-05	0.0297	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	5.65e-05	0.0291	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	5.34e-05	0.0275	CbGpPWpGaD
Latanoprost—Conjunctivitis—Apraclonidine—glaucoma	5.12e-05	0.00127	CcSEcCtD
Latanoprost—Stinging—Timolol—glaucoma	5.12e-05	0.00127	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Other—SMO—glaucoma	5.11e-05	0.0263	CbGpPWpGaD
Latanoprost—Toxic epidermal necrolysis—Dorzolamide—glaucoma	5.05e-05	0.00125	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	4.89e-05	0.0252	CbGpPWpGaD
Latanoprost—Bronchitis—Brimonidine—glaucoma	4.88e-05	0.00121	CcSEcCtD
Latanoprost—Eye irritation—Timolol—glaucoma	4.85e-05	0.0012	CcSEcCtD
Latanoprost—Asthma—Travoprost—glaucoma	4.82e-05	0.0012	CcSEcCtD
Latanoprost—Oedema—Carteolol—glaucoma	4.8e-05	0.00119	CcSEcCtD
Latanoprost—Photophobia—Betaxolol—glaucoma	4.76e-05	0.00118	CcSEcCtD
Latanoprost—Asthma—Brinzolamide—glaucoma	4.76e-05	0.00118	CcSEcCtD
Latanoprost—Chest pain—Levobunolol—glaucoma	4.73e-05	0.00117	CcSEcCtD
Latanoprost—Angina pectoris—Dorzolamide—glaucoma	4.72e-05	0.00117	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Metipranolol—glaucoma	4.72e-05	0.00117	CcSEcCtD
Latanoprost—Angina pectoris—Travoprost—glaucoma	4.7e-05	0.00116	CcSEcCtD
Latanoprost—Dry eye—Betaxolol—glaucoma	4.69e-05	0.00116	CcSEcCtD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	4.68e-05	0.0241	CbGpPWpGaD
Latanoprost—Bronchitis—Dorzolamide—glaucoma	4.66e-05	0.00115	CcSEcCtD
Latanoprost—Angina pectoris—Brinzolamide—glaucoma	4.64e-05	0.00115	CcSEcCtD
Latanoprost—Bronchitis—Travoprost—glaucoma	4.64e-05	0.00115	CcSEcCtD
Latanoprost—Dyspnoea—Metipranolol—glaucoma	4.62e-05	0.00114	CcSEcCtD
Latanoprost—Bronchitis—Brinzolamide—glaucoma	4.58e-05	0.00114	CcSEcCtD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	4.56e-05	0.0235	CbGpPWpGaD
Latanoprost—Connective tissue disorder—Bimatoprost—glaucoma	4.51e-05	0.00112	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Dorzolamide—glaucoma	4.5e-05	0.00112	CcSEcCtD
Latanoprost—Lacrimation increased—Timolol—glaucoma	4.5e-05	0.00111	CcSEcCtD
Latanoprost—Discomfort—Methazolamide—glaucoma	4.48e-05	0.00111	CcSEcCtD
Latanoprost—Angina pectoris—Pilocarpine—glaucoma	4.46e-05	0.00111	CcSEcCtD
Latanoprost—Bronchitis—Pilocarpine—glaucoma	4.4e-05	0.00109	CcSEcCtD
Latanoprost—SLC22A1—Neurotransmitter Release Cycle—SLC6A1—glaucoma	4.4e-05	0.0227	CbGpPWpGaD
Latanoprost—Conjunctivitis—Brimonidine—glaucoma	4.4e-05	0.00109	CcSEcCtD
Latanoprost—Dyspnoea—Carteolol—glaucoma	4.28e-05	0.00106	CcSEcCtD
Latanoprost—Mediastinal disorder—Apraclonidine—glaucoma	4.26e-05	0.00106	CcSEcCtD
Latanoprost—Conjunctivitis—Dorzolamide—glaucoma	4.2e-05	0.00104	CcSEcCtD
Latanoprost—Urinary tract infection—Dorzolamide—glaucoma	4.2e-05	0.00104	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	4.19e-05	0.0216	CbGpPWpGaD
Latanoprost—Conjunctivitis—Travoprost—glaucoma	4.18e-05	0.00104	CcSEcCtD
Latanoprost—Urinary tract infection—Travoprost—glaucoma	4.18e-05	0.00104	CcSEcCtD
Latanoprost—Mediastinal disorder—Bimatoprost—glaucoma	4.13e-05	0.00102	CcSEcCtD
Latanoprost—Conjunctivitis—Brinzolamide—glaucoma	4.13e-05	0.00102	CcSEcCtD
Latanoprost—Erythema—Apraclonidine—glaucoma	4.12e-05	0.00102	CcSEcCtD
Latanoprost—Eczema—Betaxolol—glaucoma	4.1e-05	0.00102	CcSEcCtD
Latanoprost—Eye pain—Betaxolol—glaucoma	4.08e-05	0.00101	CcSEcCtD
Latanoprost—Dyspnoea—Levobunolol—glaucoma	4.04e-05	0.001	CcSEcCtD
Latanoprost—Erythema—Bimatoprost—glaucoma	3.99e-05	0.00099	CcSEcCtD
Latanoprost—Conjunctivitis—Pilocarpine—glaucoma	3.97e-05	0.000984	CcSEcCtD
Latanoprost—Urinary tract infection—Pilocarpine—glaucoma	3.97e-05	0.000984	CcSEcCtD
Latanoprost—Pain—Carbachol—glaucoma	3.94e-05	0.000976	CcSEcCtD
Latanoprost—Photophobia—Timolol—glaucoma	3.89e-05	0.000965	CcSEcCtD
Latanoprost—Vision blurred—Apraclonidine—glaucoma	3.88e-05	0.000962	CcSEcCtD
Latanoprost—Pain—Levobunolol—glaucoma	3.88e-05	0.000961	CcSEcCtD
Latanoprost—Dry eye—Timolol—glaucoma	3.83e-05	0.000949	CcSEcCtD
Latanoprost—Connective tissue disorder—Travoprost—glaucoma	3.8e-05	0.000941	CcSEcCtD
Latanoprost—Vision blurred—Bimatoprost—glaucoma	3.76e-05	0.000933	CcSEcCtD
Latanoprost—Connective tissue disorder—Brinzolamide—glaucoma	3.75e-05	0.000929	CcSEcCtD
Latanoprost—Mediastinal disorder—Brimonidine—glaucoma	3.66e-05	0.000907	CcSEcCtD
Latanoprost—Asthma—Clonidine—glaucoma	3.66e-05	0.000906	CcSEcCtD
Latanoprost—Erythema—Brimonidine—glaucoma	3.54e-05	0.000876	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—PEX19—glaucoma	3.52e-05	0.0181	CbGpPWpGaD
Latanoprost—Chest pain—Apraclonidine—glaucoma	3.51e-05	0.000869	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	3.48e-05	0.000863	CcSEcCtD
Latanoprost—Mediastinal disorder—Travoprost—glaucoma	3.48e-05	0.000863	CcSEcCtD
Latanoprost—Discomfort—Apraclonidine—glaucoma	3.46e-05	0.000858	CcSEcCtD
Latanoprost—Mediastinal disorder—Brinzolamide—glaucoma	3.44e-05	0.000852	CcSEcCtD
Latanoprost—Dizziness—Metipranolol—glaucoma	3.42e-05	0.000849	CcSEcCtD
Latanoprost—Chest pain—Bimatoprost—glaucoma	3.4e-05	0.000842	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Clonidine—glaucoma	3.4e-05	0.000842	CcSEcCtD
Latanoprost—Tafluprost—PTGS2—glaucoma	3.39e-05	0.0256	CrCbGaD
Latanoprost—Erythema—Dorzolamide—glaucoma	3.38e-05	0.000837	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	3.38e-05	0.000837	CcSEcCtD
Latanoprost—Erythema—Travoprost—glaucoma	3.36e-05	0.000833	CcSEcCtD
Latanoprost—Oedema—Apraclonidine—glaucoma	3.36e-05	0.000833	CcSEcCtD
Latanoprost—Pruritus—Diclofenamide—glaucoma	3.34e-05	0.000827	CcSEcCtD
Latanoprost—Eye pain—Timolol—glaucoma	3.33e-05	0.000826	CcSEcCtD
Latanoprost—Vision blurred—Brimonidine—glaucoma	3.33e-05	0.000826	CcSEcCtD
Latanoprost—Erythema—Brinzolamide—glaucoma	3.32e-05	0.000823	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Betaxolol—glaucoma	3.32e-05	0.000822	CcSEcCtD
Latanoprost—Nervous system disorder—Apraclonidine—glaucoma	3.3e-05	0.000817	CcSEcCtD
Latanoprost—Back pain—Dorzolamide—glaucoma	3.27e-05	0.000809	CcSEcCtD
Latanoprost—Rash—Metipranolol—glaucoma	3.27e-05	0.000809	CcSEcCtD
Latanoprost—Skin disorder—Apraclonidine—glaucoma	3.26e-05	0.000809	CcSEcCtD
Latanoprost—Dermatitis—Metipranolol—glaucoma	3.26e-05	0.000809	CcSEcCtD
Latanoprost—Back pain—Travoprost—glaucoma	3.25e-05	0.000806	CcSEcCtD
Latanoprost—Headache—Metipranolol—glaucoma	3.24e-05	0.000804	CcSEcCtD
Latanoprost—Back pain—Brinzolamide—glaucoma	3.21e-05	0.000796	CcSEcCtD
Latanoprost—Pruritus—Levobunolol—glaucoma	3.21e-05	0.000795	CcSEcCtD
Latanoprost—Nervous system disorder—Bimatoprost—glaucoma	3.2e-05	0.000792	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—OPN4—glaucoma	3.19e-05	0.0164	CbGpPWpGaD
Latanoprost—Asthma—Betaxolol—glaucoma	3.18e-05	0.000789	CcSEcCtD
Latanoprost—Vision blurred—Dorzolamide—glaucoma	3.18e-05	0.000789	CcSEcCtD
Latanoprost—Dizziness—Carteolol—glaucoma	3.17e-05	0.000786	CcSEcCtD
Latanoprost—Urinary tract infection—Clonidine—glaucoma	3.17e-05	0.000785	CcSEcCtD
Latanoprost—Vision blurred—Travoprost—glaucoma	3.17e-05	0.000785	CcSEcCtD
Latanoprost—Skin disorder—Bimatoprost—glaucoma	3.17e-05	0.000784	CcSEcCtD
Latanoprost—Vision blurred—Brinzolamide—glaucoma	3.13e-05	0.000775	CcSEcCtD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	3.12e-05	0.0161	CbGpPWpGaD
Latanoprost—Dizziness—Diclofenamide—glaucoma	3.12e-05	0.000773	CcSEcCtD
Latanoprost—Angina pectoris—Betaxolol—glaucoma	3.1e-05	0.000769	CcSEcCtD
Latanoprost—Discomfort—Acetazolamide—glaucoma	3.1e-05	0.000768	CcSEcCtD
Latanoprost—Back pain—Pilocarpine—glaucoma	3.09e-05	0.000765	CcSEcCtD
Latanoprost—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	3.08e-05	0.0159	CbGpPWpGaD
Latanoprost—Musculoskeletal discomfort—Apraclonidine—glaucoma	3.06e-05	0.000759	CcSEcCtD
Latanoprost—Bronchitis—Betaxolol—glaucoma	3.06e-05	0.000759	CcSEcCtD
Latanoprost—Dizziness—Carbachol—glaucoma	3.04e-05	0.000755	CcSEcCtD
Latanoprost—Arthralgia—Brimonidine—glaucoma	3.01e-05	0.000746	CcSEcCtD
Latanoprost—Chest pain—Brimonidine—glaucoma	3.01e-05	0.000746	CcSEcCtD
Latanoprost—Diplopia—Timolol—glaucoma	3.01e-05	0.000746	CcSEcCtD
Latanoprost—Vision blurred—Pilocarpine—glaucoma	3.01e-05	0.000745	CcSEcCtD
Latanoprost—Headache—Carteolol—glaucoma	3.01e-05	0.000745	CcSEcCtD
Latanoprost—Dizziness—Levobunolol—glaucoma	3e-05	0.000743	CcSEcCtD
Latanoprost—Dyspnoea—Apraclonidine—glaucoma	3e-05	0.000743	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	2.99e-05	0.000741	CcSEcCtD
Latanoprost—Rash—Diclofenamide—glaucoma	2.97e-05	0.000737	CcSEcCtD
Latanoprost—Discomfort—Brimonidine—glaucoma	2.97e-05	0.000737	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Betaxolol—glaucoma	2.96e-05	0.000733	CcSEcCtD
Latanoprost—Headache—Diclofenamide—glaucoma	2.95e-05	0.000732	CcSEcCtD
Latanoprost—Dyspnoea—Bimatoprost—glaucoma	2.91e-05	0.00072	CcSEcCtD
Latanoprost—Rash—Carbachol—glaucoma	2.9e-05	0.000719	CcSEcCtD
Latanoprost—Dermatitis—Carbachol—glaucoma	2.9e-05	0.000719	CcSEcCtD
Latanoprost—Oedema—Brimonidine—glaucoma	2.89e-05	0.000715	CcSEcCtD
Latanoprost—Headache—Carbachol—glaucoma	2.88e-05	0.000715	CcSEcCtD
Latanoprost—Arthralgia—Dorzolamide—glaucoma	2.87e-05	0.000712	CcSEcCtD
Latanoprost—Chest pain—Dorzolamide—glaucoma	2.87e-05	0.000712	CcSEcCtD
Latanoprost—Pain—Apraclonidine—glaucoma	2.87e-05	0.000712	CcSEcCtD
Latanoprost—Arthralgia—Travoprost—glaucoma	2.86e-05	0.000709	CcSEcCtD
Latanoprost—Chest pain—Travoprost—glaucoma	2.86e-05	0.000709	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	2.84e-05	0.000704	CcSEcCtD
Latanoprost—Headache—Levobunolol—glaucoma	2.84e-05	0.000704	CcSEcCtD
Latanoprost—Discomfort—Dorzolamide—glaucoma	2.84e-05	0.000704	CcSEcCtD
Latanoprost—Nervous system disorder—Brimonidine—glaucoma	2.83e-05	0.000701	CcSEcCtD
Latanoprost—Discomfort—Travoprost—glaucoma	2.83e-05	0.000701	CcSEcCtD
Latanoprost—Arthralgia—Brinzolamide—glaucoma	2.83e-05	0.0007	CcSEcCtD
Latanoprost—Chest pain—Brinzolamide—glaucoma	2.83e-05	0.0007	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	2.81e-05	0.000696	CcSEcCtD
Latanoprost—Skin disorder—Brimonidine—glaucoma	2.8e-05	0.000695	CcSEcCtD
Latanoprost—Discomfort—Brinzolamide—glaucoma	2.79e-05	0.000692	CcSEcCtD
Latanoprost—Pain—Bimatoprost—glaucoma	2.79e-05	0.000691	CcSEcCtD
Latanoprost—Conjunctivitis—Betaxolol—glaucoma	2.76e-05	0.000684	CcSEcCtD
Latanoprost—Oedema—Dorzolamide—glaucoma	2.76e-05	0.000683	CcSEcCtD
Latanoprost—Oedema—Travoprost—glaucoma	2.74e-05	0.00068	CcSEcCtD
Latanoprost—Rash—Methazolamide—glaucoma	2.74e-05	0.000679	CcSEcCtD
Latanoprost—Dermatitis—Methazolamide—glaucoma	2.74e-05	0.000678	CcSEcCtD
Latanoprost—Headache—Methazolamide—glaucoma	2.72e-05	0.000674	CcSEcCtD
Latanoprost—Chest pain—Pilocarpine—glaucoma	2.72e-05	0.000673	CcSEcCtD
Latanoprost—Arthralgia—Pilocarpine—glaucoma	2.72e-05	0.000673	CcSEcCtD
Latanoprost—Nervous system disorder—Travoprost—glaucoma	2.69e-05	0.000667	CcSEcCtD
Latanoprost—Discomfort—Pilocarpine—glaucoma	2.68e-05	0.000665	CcSEcCtD
Latanoprost—Skin disorder—Travoprost—glaucoma	2.67e-05	0.00066	CcSEcCtD
Latanoprost—Nervous system disorder—Brinzolamide—glaucoma	2.66e-05	0.000658	CcSEcCtD
Latanoprost—Mediastinal disorder—Clonidine—glaucoma	2.64e-05	0.000654	CcSEcCtD
Latanoprost—Skin disorder—Brinzolamide—glaucoma	2.63e-05	0.000652	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Brimonidine—glaucoma	2.63e-05	0.000652	CcSEcCtD
Latanoprost—Oedema—Pilocarpine—glaucoma	2.6e-05	0.000645	CcSEcCtD
Latanoprost—Asthma—Timolol—glaucoma	2.6e-05	0.000645	CcSEcCtD
Latanoprost—Dyspnoea—Brimonidine—glaucoma	2.57e-05	0.000638	CcSEcCtD
Latanoprost—Erythema—Clonidine—glaucoma	2.55e-05	0.000631	CcSEcCtD
Latanoprost—Angina pectoris—Timolol—glaucoma	2.53e-05	0.000628	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Dorzolamide—glaucoma	2.51e-05	0.000622	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Travoprost—glaucoma	2.5e-05	0.00062	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Brinzolamide—glaucoma	2.47e-05	0.000612	CcSEcCtD
Latanoprost—Pain—Brimonidine—glaucoma	2.47e-05	0.000612	CcSEcCtD
Latanoprost—Dyspnoea—Dorzolamide—glaucoma	2.46e-05	0.000609	CcSEcCtD
Latanoprost—Dyspnoea—Travoprost—glaucoma	2.45e-05	0.000606	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Timolol—glaucoma	2.42e-05	0.000599	CcSEcCtD
Latanoprost—Dyspnoea—Brinzolamide—glaucoma	2.42e-05	0.000599	CcSEcCtD
Latanoprost—Vision blurred—Clonidine—glaucoma	2.4e-05	0.000595	CcSEcCtD
Latanoprost—Pruritus—Apraclonidine—glaucoma	2.38e-05	0.000589	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC4A4—glaucoma	2.38e-05	0.0123	CbGpPWpGaD
Latanoprost—Musculoskeletal discomfort—Pilocarpine—glaucoma	2.37e-05	0.000588	CcSEcCtD
Latanoprost—Pain—Dorzolamide—glaucoma	2.36e-05	0.000584	CcSEcCtD
Latanoprost—Pain—Travoprost—glaucoma	2.35e-05	0.000581	CcSEcCtD
Latanoprost—Dyspnoea—Pilocarpine—glaucoma	2.32e-05	0.000575	CcSEcCtD
Latanoprost—Pain—Brinzolamide—glaucoma	2.32e-05	0.000574	CcSEcCtD
Latanoprost—Pruritus—Bimatoprost—glaucoma	2.31e-05	0.000571	CcSEcCtD
Latanoprost—Mediastinal disorder—Betaxolol—glaucoma	2.3e-05	0.000569	CcSEcCtD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	2.28e-05	0.0118	CbGpPWpGaD
Latanoprost—Conjunctivitis—Timolol—glaucoma	2.25e-05	0.000559	CcSEcCtD
Latanoprost—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	2.25e-05	0.0116	CbGpPWpGaD
Latanoprost—Pain—Pilocarpine—glaucoma	2.23e-05	0.000552	CcSEcCtD
Latanoprost—Dizziness—Apraclonidine—glaucoma	2.22e-05	0.000551	CcSEcCtD
Latanoprost—Erythema—Betaxolol—glaucoma	2.22e-05	0.00055	CcSEcCtD
Latanoprost—Arthralgia—Clonidine—glaucoma	2.17e-05	0.000538	CcSEcCtD
Latanoprost—Chest pain—Clonidine—glaucoma	2.17e-05	0.000538	CcSEcCtD
Latanoprost—Dizziness—Bimatoprost—glaucoma	2.15e-05	0.000534	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	2.15e-05	0.000534	CcSEcCtD
Latanoprost—Discomfort—Clonidine—glaucoma	2.14e-05	0.000531	CcSEcCtD
Latanoprost—Dermatitis—Apraclonidine—glaucoma	2.12e-05	0.000525	CcSEcCtD
Latanoprost—Headache—Apraclonidine—glaucoma	2.11e-05	0.000522	CcSEcCtD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	2.1e-05	0.0108	CbGpPWpGaD
Latanoprost—Vision blurred—Betaxolol—glaucoma	2.09e-05	0.000518	CcSEcCtD
Latanoprost—Oedema—Clonidine—glaucoma	2.08e-05	0.000515	CcSEcCtD
Latanoprost—Rash—Bimatoprost—glaucoma	2.05e-05	0.000509	CcSEcCtD
Latanoprost—Dermatitis—Bimatoprost—glaucoma	2.05e-05	0.000509	CcSEcCtD
Latanoprost—Connective tissue disorder—Timolol—glaucoma	2.05e-05	0.000507	CcSEcCtD
Latanoprost—Pruritus—Brimonidine—glaucoma	2.04e-05	0.000506	CcSEcCtD
Latanoprost—Headache—Bimatoprost—glaucoma	2.04e-05	0.000506	CcSEcCtD
Latanoprost—Nervous system disorder—Clonidine—glaucoma	2.04e-05	0.000505	CcSEcCtD
Latanoprost—Skin disorder—Clonidine—glaucoma	2.02e-05	0.000501	CcSEcCtD
Latanoprost—Dizziness—Acetazolamide—glaucoma	1.99e-05	0.000493	CcSEcCtD
Latanoprost—Pruritus—Dorzolamide—glaucoma	1.95e-05	0.000483	CcSEcCtD
Latanoprost—Pruritus—Travoprost—glaucoma	1.94e-05	0.000481	CcSEcCtD
Latanoprost—Pruritus—Brinzolamide—glaucoma	1.92e-05	0.000475	CcSEcCtD
Latanoprost—Dizziness—Brimonidine—glaucoma	1.91e-05	0.000473	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Clonidine—glaucoma	1.89e-05	0.00047	CcSEcCtD
Latanoprost—PTGFR—G alpha (q) signalling events—EDN1—glaucoma	1.89e-05	0.00976	CbGpPWpGaD
Latanoprost—Chest pain—Betaxolol—glaucoma	1.89e-05	0.000468	CcSEcCtD
Latanoprost—Arthralgia—Betaxolol—glaucoma	1.89e-05	0.000468	CcSEcCtD
Latanoprost—Headache—Acetazolamide—glaucoma	1.88e-05	0.000467	CcSEcCtD
Latanoprost—Mediastinal disorder—Timolol—glaucoma	1.88e-05	0.000465	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	1.88e-05	0.000465	CcSEcCtD
Latanoprost—Discomfort—Betaxolol—glaucoma	1.87e-05	0.000462	CcSEcCtD
Latanoprost—Dyspnoea—Clonidine—glaucoma	1.85e-05	0.000459	CcSEcCtD
Latanoprost—Pruritus—Pilocarpine—glaucoma	1.84e-05	0.000457	CcSEcCtD
Latanoprost—Dizziness—Dorzolamide—glaucoma	1.82e-05	0.000452	CcSEcCtD
Latanoprost—Rash—Brimonidine—glaucoma	1.82e-05	0.000451	CcSEcCtD
Latanoprost—Dermatitis—Brimonidine—glaucoma	1.82e-05	0.00045	CcSEcCtD
Latanoprost—Dizziness—Travoprost—glaucoma	1.81e-05	0.00045	CcSEcCtD
Latanoprost—Erythema—Timolol—glaucoma	1.81e-05	0.000449	CcSEcCtD
Latanoprost—Oedema—Betaxolol—glaucoma	1.81e-05	0.000449	CcSEcCtD
Latanoprost—Headache—Brimonidine—glaucoma	1.81e-05	0.000448	CcSEcCtD
Latanoprost—PTGFR—GPCR downstream signaling—OPN4—glaucoma	1.8e-05	0.00929	CbGpPWpGaD
Latanoprost—Dizziness—Brinzolamide—glaucoma	1.79e-05	0.000444	CcSEcCtD
Latanoprost—Pain—Clonidine—glaucoma	1.78e-05	0.000441	CcSEcCtD
Latanoprost—Nervous system disorder—Betaxolol—glaucoma	1.78e-05	0.00044	CcSEcCtD
Latanoprost—Skin disorder—Betaxolol—glaucoma	1.76e-05	0.000436	CcSEcCtD
Latanoprost—Rash—Dorzolamide—glaucoma	1.74e-05	0.000431	CcSEcCtD
Latanoprost—Dermatitis—Dorzolamide—glaucoma	1.74e-05	0.00043	CcSEcCtD
Latanoprost—Rash—Travoprost—glaucoma	1.73e-05	0.000429	CcSEcCtD
Latanoprost—Dermatitis—Travoprost—glaucoma	1.73e-05	0.000428	CcSEcCtD
Latanoprost—Headache—Dorzolamide—glaucoma	1.73e-05	0.000428	CcSEcCtD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—SLC6A13—glaucoma	1.72e-05	0.00889	CbGpPWpGaD
Latanoprost—Dizziness—Pilocarpine—glaucoma	1.72e-05	0.000427	CcSEcCtD
Latanoprost—Headache—Travoprost—glaucoma	1.72e-05	0.000426	CcSEcCtD
Latanoprost—Rash—Brinzolamide—glaucoma	1.71e-05	0.000423	CcSEcCtD
Latanoprost—Vision blurred—Timolol—glaucoma	1.71e-05	0.000423	CcSEcCtD
Latanoprost—Dermatitis—Brinzolamide—glaucoma	1.71e-05	0.000423	CcSEcCtD
Latanoprost—Headache—Brinzolamide—glaucoma	1.7e-05	0.000421	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	1.69e-05	0.00872	CbGpPWpGaD
Latanoprost—Musculoskeletal discomfort—Betaxolol—glaucoma	1.65e-05	0.000409	CcSEcCtD
Latanoprost—Rash—Pilocarpine—glaucoma	1.64e-05	0.000407	CcSEcCtD
Latanoprost—Dermatitis—Pilocarpine—glaucoma	1.64e-05	0.000407	CcSEcCtD
Latanoprost—PTGFR—Signaling by GPCR—OPN4—glaucoma	1.64e-05	0.00843	CbGpPWpGaD
Latanoprost—Headache—Pilocarpine—glaucoma	1.63e-05	0.000404	CcSEcCtD
Latanoprost—Dyspnoea—Betaxolol—glaucoma	1.61e-05	0.0004	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC6A13—glaucoma	1.59e-05	0.00817	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—PEX19—glaucoma	1.58e-05	0.00813	CbGpPWpGaD
Latanoprost—Pain—Betaxolol—glaucoma	1.55e-05	0.000384	CcSEcCtD
Latanoprost—Arthralgia—Timolol—glaucoma	1.54e-05	0.000382	CcSEcCtD
Latanoprost—Chest pain—Timolol—glaucoma	1.54e-05	0.000382	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	1.53e-05	0.00038	CcSEcCtD
Latanoprost—Discomfort—Timolol—glaucoma	1.52e-05	0.000378	CcSEcCtD
Latanoprost—Oedema—Timolol—glaucoma	1.48e-05	0.000367	CcSEcCtD
Latanoprost—Pruritus—Clonidine—glaucoma	1.47e-05	0.000365	CcSEcCtD
Latanoprost—Nervous system disorder—Timolol—glaucoma	1.45e-05	0.000359	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—SMO—glaucoma	1.45e-05	0.00746	CbGpPWpGaD
Latanoprost—Skin disorder—Timolol—glaucoma	1.44e-05	0.000356	CcSEcCtD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	1.4e-05	0.00721	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LRP12—glaucoma	1.39e-05	0.00719	CbGpPWpGaD
Latanoprost—Dizziness—Clonidine—glaucoma	1.38e-05	0.000341	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Timolol—glaucoma	1.35e-05	0.000334	CcSEcCtD
Latanoprost—SLC22A1—Neuronal System—SLC6A13—glaucoma	1.32e-05	0.00681	CbGpPWpGaD
Latanoprost—Dyspnoea—Timolol—glaucoma	1.32e-05	0.000327	CcSEcCtD
Latanoprost—Rash—Clonidine—glaucoma	1.31e-05	0.000325	CcSEcCtD
Latanoprost—Dermatitis—Clonidine—glaucoma	1.31e-05	0.000325	CcSEcCtD
Latanoprost—Headache—Clonidine—glaucoma	1.3e-05	0.000323	CcSEcCtD
Latanoprost—Pruritus—Betaxolol—glaucoma	1.28e-05	0.000317	CcSEcCtD
Latanoprost—Pain—Timolol—glaucoma	1.26e-05	0.000313	CcSEcCtD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—SLC6A1—glaucoma	1.26e-05	0.00651	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.25e-05	0.00646	CbGpPWpGaD
Latanoprost—Dizziness—Betaxolol—glaucoma	1.2e-05	0.000297	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.16e-05	0.00598	CbGpPWpGaD
Latanoprost—Rash—Betaxolol—glaucoma	1.14e-05	0.000283	CcSEcCtD
Latanoprost—Dermatitis—Betaxolol—glaucoma	1.14e-05	0.000283	CcSEcCtD
Latanoprost—Headache—Betaxolol—glaucoma	1.13e-05	0.000281	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.09e-05	0.00564	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	1.06e-05	0.00549	CbGpPWpGaD
Latanoprost—Pruritus—Timolol—glaucoma	1.05e-05	0.000259	CcSEcCtD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	1.02e-05	0.00528	CbGpPWpGaD
Latanoprost—Dizziness—Timolol—glaucoma	9.78e-06	0.000242	CcSEcCtD
Latanoprost—SLC22A1—Neuronal System—SLC6A1—glaucoma	9.67e-06	0.00499	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—OPN4—glaucoma	9.66e-06	0.00498	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—EDN1—glaucoma	9.54e-06	0.00492	CbGpPWpGaD
Latanoprost—Rash—Timolol—glaucoma	9.32e-06	0.000231	CcSEcCtD
Latanoprost—Dermatitis—Timolol—glaucoma	9.32e-06	0.000231	CcSEcCtD
Latanoprost—Headache—Timolol—glaucoma	9.26e-06	0.00023	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—HEYL—glaucoma	8.98e-06	0.00463	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CA5A—glaucoma	8.68e-06	0.00448	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NARFL—glaucoma	8.68e-06	0.00448	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—C3—glaucoma	8.33e-06	0.0043	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—SMO—glaucoma	7.43e-06	0.00383	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.1e-06	0.00366	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RPTOR—glaucoma	6.81e-06	0.00351	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NCK2—glaucoma	6.59e-06	0.0034	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HDAC9—glaucoma	5.61e-06	0.00289	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—EDN1—glaucoma	5.39e-06	0.00278	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.2e-06	0.00268	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—EDN1—glaucoma	4.9e-06	0.00252	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—C3—glaucoma	4.71e-06	0.00243	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SMO—glaucoma	4.39e-06	0.00226	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—C3—glaucoma	4.28e-06	0.00221	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CA1—glaucoma	4.24e-06	0.00219	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CTSA—glaucoma	4.11e-06	0.00212	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NTRK2—glaucoma	4.01e-06	0.00207	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CA2—glaucoma	3.88e-06	0.002	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NGFR—glaucoma	3.44e-06	0.00178	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NTRK1—glaucoma	3.27e-06	0.00169	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN2B—glaucoma	3.01e-06	0.00155	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EDN1—glaucoma	2.89e-06	0.00149	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TXN—glaucoma	2.73e-06	0.00141	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NGF—glaucoma	2.66e-06	0.00137	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—C3—glaucoma	2.53e-06	0.0013	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APOE—glaucoma	2.35e-06	0.00121	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CAV1—glaucoma	2.33e-06	0.0012	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FN1—glaucoma	2.22e-06	0.00114	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—BAD—glaucoma	2.19e-06	0.00113	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTT1—glaucoma	2.12e-06	0.00109	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOS3—glaucoma	1.76e-06	0.000909	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP1B1—glaucoma	1.69e-06	0.00087	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCA1—glaucoma	1.69e-06	0.00087	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN1B—glaucoma	1.53e-06	0.000787	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MMP9—glaucoma	1.41e-06	0.000729	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTM1—glaucoma	1.35e-06	0.000696	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VEGFA—glaucoma	1.27e-06	0.000655	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MTHFR—glaucoma	1.19e-06	0.000615	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APOE—glaucoma	1.11e-06	0.000573	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CAV1—glaucoma	1.1e-06	0.000567	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TP53—glaucoma	9.59e-07	0.000495	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NOS3—glaucoma	8.32e-07	0.000429	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTGS2—glaucoma	7.61e-07	0.000392	CbGpPWpGaD
